ASIA-PACIFIC CELLULITE TREATMENT MARKET 2023-2030

Consumer Goods & Services | Personal Care Products

ASIA-PACIFIC CELLULITE TREATMENT MARKET 2023-2030

Market by Cellulite Type, Procedure Type, End-user, and Country Outlook | Forecast 2023-2030

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton Market Research’s report, the cellulite treatment market in the Asia-Pacific region is expected to grow at a compound annual growth rate of 9.83% between the forecast years 2023 and 2030.

Report scope can be customized per your requirements - Request Free Sample Report 

The studied region comprises countries such as:

•         China

•         Japan

•         South Korea

•         India

•         Australia & New Zealand 

•         ASEAN Countries

•         Rest of Asia-Pacific

India has established itself as a prominent player in the cellulite treatment market, expected to witness the fastest growth. This growth is fueled by the increasing number of aesthetic procedures and a large pool of qualified medical professionals in the country. Moreover, the high prevalence of obesity and a rapidly growing elderly population are expected to surge the demand for cellulite treatments. India is also known for providing affordable treatment options, making it an attractive destination for medical tourism. As the medical tourism industry continues to grow, it is expected to further boost the demand for various procedures. Given the above-stated factors, India is poised to continue its growth trajectory in the cellulite treatment market. 

South Korea’s beauty industry has gained significant prominence globally, owing to innovative ingredients and appealing packaging. In 2020, the cosmetics sector in the country was estimated to be worth $6.8 billion. Additionally, the nation has a significant number of plastic surgeons, with approximately 2,600 professionals operating in 2021. The quality of healthcare services available is expected to be a major driver of market growth as consumers prioritize safety and effectiveness when choosing beauty treatments. Moreover, the rising awareness about cosmetic treatments and the increasing number of individuals focused on their appearance are expected to further propel the South Korean cellulite treatment market growth during the forecast period.

Minimally invasive procedures refer to a range of surgical techniques that are designed to minimize the size of surgical incisions. This approach provides numerous benefits, including faster wound healing times, reduced risk of infections, and decreased post-surgical pain. The market’s growth is determined based on procedure type, cellulite type, and end-user. The procedure type segment includes non-invasive, minimally invasive, and topical.

The eminent companies in the market include Candela Medical Corporation, Endo International Plc, AbbVie Inc, Galderma SA, and Cutera Inc.

Galderma SA is a Switzerland-based dermatology company with a global presence across Latin America, Europe, the Middle East, Africa, North America, and Asia-Pacific. It specializes in science-based solutions and medical services for skin health, providing effective and reliable products and services that cater to diverse needs. One of the company’s products is Sculptra, a treatment that utilizes the skin’s natural ability to renew collagen production and achieve a more youthful appearance.

 

Key deliverables of the report:

      Market CAGR during the forecasting years 2023-2030

      Detailed data highlighting key insights, industry components, and market strategies


      Comprehensive information and estimation of the cellulite treatment market revenue growth in the Asia-Pacific and its influence on the parent market


      In-depth study of forthcoming trends in consumer behavioral patterns


      A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces


      A wide-ranging study of factors that will challenge the APAC cellulite treatment market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

 NORTH AMERICA BETA GLUCAN MARKET 2019-2027
Consumer Goods & Services

NORTH AMERICA BETA GLUCAN MARKET 2019-2027

Market By Category, Applicatio ..

VIEW REPORT
ARGENTINA ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET 2021-2026
Consumer Goods & Services

ARGENTINA ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET 2021-2026

Market by RTD Type | Forecast ..

VIEW REPORT
ARGENTINA ALCOHOLIC SPIRITS MARKET 2021-2026
Consumer Goods & Services

ARGENTINA ALCOHOLIC SPIRITS MARKET 2021-2026

Market by Product Type | Forec ..

VIEW REPORT
ASIA-PACIFIC ALTERNATIVE SWEETENERS MARKET 2021-2028
Consumer Goods & Services

ASIA-PACIFIC ALTERNATIVE SWEETENERS MARKET 2021-2028

Market by Product, Application ..

VIEW REPORT
ASIA-PACIFIC ANIMAL NUTRITION MARKET 2019-2028
Consumer Goods & Services

ASIA-PACIFIC ANIMAL NUTRITION MARKET 2019-2028

Market By Product Type, Specie ..

VIEW REPORT
ASIA-PACIFIC ANTI-ACNE DERMAL PATCH MARKET 2024-2032
Consumer Goods & Services

ASIA-PACIFIC ANTI-ACNE DERMAL PATCH MARKET 2024-2032

Market by Ingredient Type, Age ..

VIEW REPORT
ASIA-PACIFIC ANTI-AGING MARKET 2019-2027
Consumer Goods & Services

ASIA-PACIFIC ANTI-AGING MARKET 2019-2027

Market By Demographics, Produc ..

VIEW REPORT
ASIA-PACIFIC BEAUTY AND PERSONAL CARE MARKET 2022-2028
Consumer Goods & Services

ASIA-PACIFIC BEAUTY AND PERSONAL CARE MARKET 2022-2028

Market by Type, Sales Channel, ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC CELLULITE TREATMENT MARKET - SUMMARY         

2. INDUSTRY OUTLOOK 

2.1.PARENT MARKET ANALYSIS   

2.2.IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET

2.2.1.COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET  

2.2.2.UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET       

2.3.PORTER’S FIVE FORCES ANALYSIS 

2.3.1.THREAT OF NEW ENTRANTS     

2.3.2.THREAT OF SUBSTITUTES        

2.3.3.BARGAINING POWER OF BUYERS      

2.3.4.BARGAINING POWER OF SUPPLIERS 

2.3.5.THREAT OF COMPETITIVE RIVALRY   

2.4.MARKET MATURITY ANALYSIS

2.5.INDUSTRY COMPONENTS       

2.5.1.RESEARCH AND DEVELOPMENT         

2.5.2.MANUFACTURING OF PRODUCT         

2.5.3.DISTRIBUTION       

2.5.4.POST-SALES MONITORING       

2.6.REGULATORY FRAMEWORK   

2.7.KEY BUYING IMPACT ANALYSIS        

2.7.1.PRICE 

2.7.2.BRAND NAME         

2.7.3.USABILITY    

2.8.KEY MARKET STRATEGIES     

2.8.1.COLLABORATIONS

2.8.2.PRODUCT LAUNCHES      

2.8.3.MERGERS & ACQUISITIONS      

2.8.4.BUSINESS DIVESTITURES & EXPANSIONS   

2.9.MARKET DRIVERS         

2.9.1.GROWING PREVALENCE OF OBESITY

2.9.2.RAPIDLY GROWING MEDICAL TOURISM SECTOR  

2.9.3.RISING DEMAND FOR AESTHETIC PROCEDURES  

2.10.MARKET CHALLENGES

2.10.1.LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT  

2.10.2.HIGH PRICE OF ADVANCED CELLULITE TREATMENT     

2.10.3.RISKS ASSOCIATED POST-TREATMENT     

2.11.MARKET OPPORTUNITIES     

2.11.1.RISING BEAUTY CONSCIOUSNESS   

2.11.2.INCREASING TREND OF ANTI-CELLULITE MASSAGE     

2.11.3.GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES   

2.11.4.RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT   

2.11.5.ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES

2.12.ANALYST PERSPECTIVE        

3. ASIA-PACIFIC CELLULITE TREATMENT MARKET – BY CELLULITE TYPE    

3.1.SOFT CELLULITE 

3.2.HARD CELLULITE 

3.3.EDEMATOUS CELLULITE         

4. ASIA-PACIFIC CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE

4.1.NON-INVASIVE     

4.2.MINIMALLY INVASIVE    

4.3.TOPICAL    

5. ASIA-PACIFIC CELLULITE TREATMENT MARKET – BY END-USER   

5.1.HOSPITALS

5.2.CLINICS AND BEAUTY CENTERS       

5.3.OTHER END-USERS       

6. ASIA-PACIFIC CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK                  

6.1.COUNTRY ANALYSIS     

6.1.1.CHINA 

6.1.1.1.CHINA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS     

6.1.2.JAPAN

6.1.2.1.JAPAN CELLULITE TREATMENT MARKET FORECAST & PROSPECTS     

6.1.3.INDIA  

6.1.3.1.INDIA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS     

6.1.4.SOUTH KOREA       

6.1.4.1.SOUTH KOREA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS   

6.1.5.ASEAN COUNTRIES         

6.1.5.1.ASEAN COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS   

6.1.6.AUSTRALIA & NEW ZEALAND    

6.1.6.1.AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET FORECAST & PROSPECTS        

6.1.7.REST OF ASIA-PACIFIC    

6.1.7.1.REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST & PROSPECTS        

7. COMPETITIVE LANDSCAPE  

7.1.JOHNSON & JOHNSON  

7.1.1.OVERVIEW   

7.1.2.PRODUCT PORTFOLIO    

7.1.3.KEY STRENGTHS   

7.1.4.KEY CHALLENGES 

7.2.ABBVIE INC

7.2.1.OVERVIEW   

7.2.2.PRODUCT PORTFOLIO    

7.2.3.KEY STRENGTHS   

7.2.4.KEY CHALLENGES 

7.3.BAUSCH HEALTH COMPANIES INC

7.3.1.OVERVIEW   

7.3.2.PRODUCT PORTFOLIO    

7.3.3.KEY STRENGTHS   

7.3.4.KEY CHALLENGES 

7.4.CUTERA INC        

7.4.1.OVERVIEW   

7.4.2.PRODUCT PORTFOLIO    

7.4.3.KEY STRENGTHS   

7.4.4.KEY CHALLENGES 

7.5.INCELER MEDIKAL         

7.5.1.OVERVIEW   

7.5.2.PRODUCT PORTFOLIO    

7.5.3.KEY STRENGTHS   

7.5.4.KEY CHALLENGES 

7.6.ZIMMER MEDIZINSYSTEME GMBH    

7.6.1.OVERVIEW   

7.6.2.PRODUCT PORTFOLIO    

7.6.3.KEY STRENGTHS   

7.6.4.KEY CHALLENGES 

7.7.GALDERMA SA    

7.7.1.OVERVIEW   

7.7.2.PRODUCT PORTFOLIO    

7.7.3.KEY STRENGTHS   

7.7.4.KEY CHALLENGES 

7.8.SIENTRA INC       

7.8.1.OVERVIEW   

7.8.2.PRODUCT PORTFOLIO    

7.8.3.KEY STRENGTHS   

7.8.4.KEY CHALLENGES 

7.9.ENDO INTERNATIONAL PLC    

7.9.1.OVERVIEW   

7.9.2.PRODUCT PORTFOLIO    

7.9.3.KEY STRENGTHS   

7.9.4.KEY CHALLENGES 

7.10.CANDELA MEDICAL CORPORATION

7.10.1.OVERVIEW 

7.10.2.PRODUCT PORTFOLIO  

7.10.3.KEY STRENGTHS 

7.10.4.KEY CHALLENGES         

8. RESEARCH METHODOLOGY & SCOPE    

8.1.RESEARCH SCOPE & DELIVERABLES         

8.1.1.OBJECTIVES OF STUDY  

8.1.2.SCOPE OF STUDY  

8.2.SOURCES OF DATA       

8.2.1.PRIMARY DATA SOURCES         

8.2.2.SECONDARY DATA SOURCES   

8.3.RESEARCH METHODOLOGY   

8.3.1.EVALUATION OF THE PROPOSED MARKET  

8.3.2.IDENTIFICATION OF DATA SOURCES  

8.3.3.ASSESSMENT OF MARKET DETERMINANTS 

8.3.4.DATA COLLECTION

8.3.5.DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION) 

TABLE 2: REGULATORY FRAMEWORK        

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES     

TABLE 5: LIST OF MERGERS & ACQUISITIONS      

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS   

TABLE 7: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)         

TABLE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)       

TABLE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)  

List of Figures

FIGURE 1: MARKET MATURITY ANALYSIS   

FIGURE 2: INDUSTRY COMPONENTS

FIGURE 3: KEY BUYING IMPACT ANALYSIS 

FIGURE 4: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)

FIGURE 5: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)       

FIGURE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)  

FIGURE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)   

FIGURE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)   

FIGURE 11: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)         

FIGURE 12: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)         

FIGURE 13: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)        

FIGURE 15: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)    

FIGURE 16: CHINA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)    

FIGURE 17: JAPAN CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)    

FIGURE 18: INDIA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)    

FIGURE 19: SOUTH KOREA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)      

FIGURE 20: ASEAN COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)        

FIGURE 21: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)    

FIGURE 22: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying